Document Type
Blog Post
Publication Date
3-23-2021
Disciplines
Nervous System Diseases
Digital USD Citation
Serbin, Kenneth P., "Tough news for Huntington’s, other neurological disease patients: Roche halts dosing in historic clinical trials on signs of inefficacy" (2021). At Risk for Huntington's Disease. 301.
https://digital.sandiego.edu/huntingtons/301